Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-679-5 | CAS number: 68-12-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- not reported
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable well-documented report which meets basic scientific principles.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 972
- Report date:
- 1972
- Reference Type:
- publication
- Title:
- OECD SIDS Dimethylformamide
- Author:
- OECD
- Year:
- 2 004
- Bibliographic source:
- also cited in OECD SIDS Dimethylformamide, Final April 2004
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- - Principle of test: BASF internal method (in principle comparable to OECD Guideline 401).
- Short description of test conditions: 5 animals/sex were treated by single gavage application with an aqueous solution of DMF.
- Parameters analysed / observed: The animals were observed for mortality and for clinical symptoms of toxicity for 7 days. Surviving animals were sacrificed for the purpose of necropsy; as well as the animals that died during the observations period. - GLP compliance:
- no
- Test type:
- other: comparable with OECD 401
- Limit test:
- no
Test material
- Reference substance name:
- Dimethylformamide
- IUPAC Name:
- Dimethylformamide
- Details on test material:
- - Name of test material (as cited in study report): Dimethylformamid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Zentralinstitut für Versuchstierzucht Hannover
- Weight at study initiation: male: 153 g (mean), female: 135 g (mean)
- Diet: Wayne-Lab-Blox, Allied Mills, Chicago, ad libitum
- Water: water ad libitum
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- no details
- Doses:
- 6400, 4000, 3200, 2500, 2000, 1600 mL/kg bw (6016, 3760, 3008, 2350, 1880, 1504 mg/kg bw - conversation in mg/kg is based on the density: d = 0.94 g/cm3).
- No. of animals per sex per dose:
- 6016 mg/kg: 3 females and 2 males
3760, 3008, 2350, 1880, 1504 mg/kg: 5 - Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 7 days
- Frequency of observations: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 3 010 mg/kg bw
- 95% CL:
- 2 480 - 3 650
- Remarks on result:
- other: conversion in mg/kg is based on the density: d= 0.94 g/cm³.
- Mortality:
- 6016 mg/kg: 1 female died within 48 h and all animals died within 7 days.
3760 mg/kg: 1 female died within 48 h and 1 male and 4 female died within 7 days.
3008 mg/kg: 3 males and 3 females died within 7 days.
1880 mg/kg: 1 male and 1 female died within 7 days.
1504 mg/kg: 1 male died within 7 days. - Clinical signs:
- other: 6016 mg/kg: 24 h post application staggering, piloerection, paresis of fore limbs was noted. 3760, 3008, 2350 mg/kg: piloerection, slight apathy. 1880 mg/kg: 4 days post application slight staggering, piloerection. 1504 mg/kg: piloerection, slight apathy.
- Gross pathology:
- 6016 mg/kg: 2x decomposition, 1x hydrothorax and lung filled with liquid. Pale liver, kidney and spleen with autolytic alterations.
3760 mg/kg: 1x lung filled with blood. Pale liver with distinct pattern on lobule.
3008 mg/kg: distinct pattern on liver lobule.
1880 mg/kg: 1x hydrothorax, 2x pattern on liver lobule, kidney and spleen decomposed. - Other findings:
- - Histopathology: 1x desquamative pneumonia
Any other information on results incl. tables
Mortality:
Dose (mg/kg) | Gender | Conc.(%) | dead within 1 h | dead within 24 h | dead within 48 h | dead within 7 days |
6016 | male | 50 | 0/2 | 0/2 | 0/2 | 2/2 |
6016 | female | 50 | 0/3 | 0/3 | 1/3 | 3/3 |
3760 | male | 25 | 0/5 | 0/5 | 0/5 | 1/5 |
3760 | female | 25 | 0/5 | 0/5 | 1/5 | 4/5 |
3008 | male | 25 | 0/5 | 0/5 | 0/5 | 3/5 |
3008 | female | 25 | 0/5 | 0/5 | 0/5 | 3/5 |
2350 | male | 25 | 0/5 | 0/5 | 0/5 | 0/5 |
2350 | female | 25 | 0/5 | 0/5 | 0/5 | 0/5 |
1880 | male | 25 | 0/5 | 0/5 | 0/5 | 1/5 |
1880 | female | 25 | 0/5 | 0/5 | 0/5 | 1/5 |
1504 | male | 25 | 0/5 | 0/5 | 0/5 | 1/5 |
1504 | female | 25 | 0/5 | 0/5 | 0/5 | 0/5 |
May be harmful if swallowed.
Applicant's summary and conclusion
- Interpretation of results:
- other:
- Remarks:
- EU GHS criteria not met
- Conclusions:
- Main symptoms observed were apathy and staggering after oral intake.
The LD50 for both sexes was determined to be 3010 mg/kg bw/day. - Executive summary:
Study design
This non GLP-study was performed similar to the OECD Test Guideline 401: Acute Oral Toxicity, following a BASF internal method.
In the study DMF was administered once by gavage as aqueous solution in concentrations of 25 % (doses from 1504 mg/kg to 3760 mg/kg bw day) and 50 % (at dose of 6016 mg/kg bw/day), respectively, to 10 Sprague-Dawely rats per group at the dose levels of 1504, 1880, 2350, 3008, and 3760 mg/kg/ bw/day and to 5 rats per group at 6016 mg/kg bw/day. Mortality and signs of toxicity were recorded 1, 24 and 48 hours and 7 days after the substance administration. Animals that died and the surviving animals were sacrificed and necropsied after the 7 -day post observation period.
Results
48 hours after substance application one animal each at both highest dose levels (6016 and 3760 mg/kg bw/day) died. After 7 days all animals died at 6016 mg/kg bw/day, 5 of 10 rats died at 3760 mg/kg bw/day and 6 of 10 rats at 3008 mg/kg bw/day. There were no dead animals at 2350 mg/kg bw/day and 2 of 10 and 1of 10 rats were dead after 7 days at 1880 and at 1504 mg/kg bw/day, respectively. At necropsy all animals that died and those sacrificed at the end of the study, discoloured livers were seen. In relation to the dose administered the main symptoms observed were apathy and staggering.
Conclusion
Main symptoms observed were apathy and staggering after oral intake. The LD50 for both sexes was determined to be 3010 mg/kg bw/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.